Filing Details

Accession Number:
0000875320-10-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-27 12:00:00
Reporting Period:
2010-01-26
Filing Date:
2010-01-27
Accepted Time:
2010-01-27 17:05:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1349077 Lisa Kelly C/O Vertex Pharmaceuticals Incorporated
130 Waverly Street
Cambridge MA 02139
Svp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-01-26 583 $39.48 24,397 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,098 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Ms. Kelly's company approved trading plan established under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $39.48 (range $39.14 to $39.63).
  3. Ms. Kelly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.